- Reuters•4 hours ago
Novozymes (NZYMb.CO), already grappling with the consequences of low oil and crop prices, is watching anxiously to see what Bayer's (BAYGn.DE) purchase of Monsanto (MON.N) will mean for the Danish group's ties with its key agricultural partner. Chief Executive Peder Holk Nielsen said in an interview that a merged Bayer-Monsanto could extend the market for the company's smart microbial crop-boosting products, known as inoculants, but added the union also brings uncertainties. Nielsen has not yet held any discussions with Bayer about the future of its strategic tie-up with Monsanto, the BioAg Alliance, but said he expected to do so before the takeover is completed.
- MarketWatch•20 hours ago
Acceleron Pharma Inc. announced Tuesday that founder John Knopf would step down as president and chief executive and be replaced by an executive from Bayer AG . Acceleron announced that Bayer's president ...
Bayer AG (BAYRY)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||99.44 - 100.55|
|52wk Range||94.36 - 135.71|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||16.47|
|Avg Vol (3m)||84,843|
|Dividend & Yield||2.87 (2.85%)|